Page last updated: 2024-08-21

alpha-aminopyridine and Cholangiocellular Carcinoma

alpha-aminopyridine has been researched along with Cholangiocellular Carcinoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Ducreux, M; Facchinetti, F; Friboulet, L; Hollebecque, A; Malka, D; Valery, M	1
Chen, MH; Chen, YY; Cheng, CT; Chiang, KC; Tsai, CY; Wu, RC; Yeh, CN; Yeh, TS	1

Other Studies

2 other study(ies) available for alpha-aminopyridine and Cholangiocellular Carcinoma

Article	Year
Cholangiocarcinoma with STRN-ALK translocation treated with ALK inhibitors. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2021, Volume: 53, Issue:12 Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Bile Duct Neoplasms; Calmodulin-Binding Proteins; Cholangiocarcinoma; Female; Humans; Lactams; Membrane Proteins; Nerve Tissue Proteins; Pyrazoles; Receptor Protein-Tyrosine Kinases; Translocation, Genetic	2021
MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients. Oncology reports, 2018, Volume: 40, Issue:3 Topics: Aminopyridines; Animals; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Cell Proliferation; Cholangiocarcinoma; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Prognosis; Proto-Oncogene Proteins c-met; Pyridones; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Tumor Cells, Cultured	2018

Article

Year

Cholangiocarcinoma with STRN-ALK translocation treated with ALK inhibitors.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2021, Volume: 53, Issue:12

Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Bile Duct Neoplasms; Calmodulin-Binding Proteins; Cholangiocarcinoma; Female; Humans; Lactams; Membrane Proteins; Nerve Tissue Proteins; Pyrazoles; Receptor Protein-Tyrosine Kinases; Translocation, Genetic

2021

MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients.

Oncology reports, 2018, Volume: 40, Issue:3

Topics: Aminopyridines; Animals; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Cell Proliferation; Cholangiocarcinoma; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Prognosis; Proto-Oncogene Proteins c-met; Pyridones; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Tumor Cells, Cultured

2018